Neuroblastoma (NB) is the most prevalent pediatric solid tumor and a leading cause of cancer-related death in children. In the present study, a novel cytotoxic role for the dietary compounds, curcumin, andrographolide, wedelolactone, dibenzoylmethane, and tanshinone IIA was identified in human S-type NB cells, SK-N-AS and SK-N-BE(2). Mechanistically, cell death appeared apoptotic by flow cytometry; however, these effects proceeded independently from both caspase-3 and p53 activation, as assessed by both genetic (shRNA) and pharmacological approaches. Notably, cell death induced by both curcumin and andrographolide was associated with decreased NFB activity and a reduction in Bcl-2 and Bcl-xL expression. Finally, curcumin and andrographolide increased cytotoxicity following co-treatment with either cisplatin or doxorubicin, two chemotherapeutic agents widely used in the clinical management of NB. Coupled with the documented safety in humans, dietary compounds may represent a potential adjunct therapy for NB.
Introduction
Neuroblastoma (NB) is a malignant tumor of the neural crest that arises within the sympathetic nervous system. NB is the most prevalent pediatric solid tumor (41% of all cases) with 7-12 cases per million children under 4 years of age and 25-51 cases per million in infants (Eisenberg et al., 1990; Stiller and Parkin, 1992) . Despite advances in radiotherapy, chemotherapy, and surgery, high grade NB patients face a poor prognosis with a cure rate below 20% (Schmidt et al., 2000) . Children recovering from NB frequently exhibit learning and memory deficits, as well as impairment of fine motor skills, due in part to the adverse effects of radiation and chemotherapy on the developing nervous system (Humpl, 1995) . The grim prognoses coupled with a dearth of effective Abbreviations: 7-AAD, 7-aminoactinomycin D; AIF, apoptosis inducing factor; IB, inhibitor of NFB; LDH, lactate dehydrogenase; NB, neuroblastoma; NFB, nuclear factor-B; N-type, neuroblastic cells; PFT-␣, pifithrin-␣; S-type, stromal (Schwannian) cells.
* treatments that minimize long-term disability emphasize the need for improved therapeutics.
The cellular and molecular changes underlying NB development and progression remain poorly understood; however, the nuclear factor-B (NFB) transcription factor paradoxically influences both NB survival (Bian et al., 2002; Karacay et al., 2004) and cell death (Bian et al., 2001) . NB are comprised of three phenotypically different cells types, N-type, I-type, and S-type cells (Biedler et al., 1973; Ross et al., 1983) , which may explain the differential effects of NFB on cellular viability. Neuroblastic (N-type) cells, the predominant cell type in NB, utilize NFB as a death-inducing signal following cytotoxic treatment (Bian et al., 2001 ) whereas constitutive NFB promotes cellular survival in Schwannian stromal (S-type) cells (Bian et al., 2002) . Both N-type and S-type cells are derived from genetically identical precursor cells and can transdifferentiate into the other cell type (Biedler et al., 1988; Mora et al., 2001) ; however, unlike N-type cells which are eradicated by medical therapies, stromal elements may persist and develop into chemoresistant clones, contributing to the frequent relapses observed in NB patients following cytotoxic treatment (Lavoie et al., 2009 ). Thus, directed targeting of S-type cells may represent an important, yet relatively unexplored strategy to reduce the likelihood of cancer remission.
Children with NB would ideally be treated with tumorspecific chemotherapeutic agents to reduce cancer growth without adversely influencing long-term neurodevelopment.
